文献速递功能神经外科

立体定向脑电图引导下射频热凝毁损癫痫灶:后续切除手术的潜在治疗与预后指标

Stereoelectroencephalography-guided radiofrequency thermocoagulation of the epileptogenic zone: a potential treatment and prognostic indicator for subsequent excision surgery.
PubMed 文献 · Acta Neurochir (Wien) · 2024-05-13

该回顾性研究分析了43例药物难治性局灶性癫痫患者接受立体定向脑电图(SEEG)引导下射频热凝毁损(RFTC)的安全性和疗效,并探讨RFTC后无发作持续时间与延迟切除手术效果的关系。排除3例后,40例中20%仅经RFTC达到Engel I级,24例接受延迟二次切除手术,总体41.7%达到Engel I级,RFTC联合延迟手术成功率为66.7%。成功组无发作持续时间(平均4.9个月,SD=2.7)显著长于失败组(平均1.9个月,SD=1.1;P=0.007)。

要点

  • SEEG引导下RFTC对药物难治性局灶性癫痫安全,术后短暂并发症发生率10%,均在一年内缓解。
  • RFTC后无发作持续时间较长(成功组平均4.9个月)与后续切除手术成功相关(P=0.007)。
  • RFTC术前存在病灶性发现的患者比例更高(p=0.01),且与更长的癫痫复发时间相关(p<0.05)。

核心结论

  • SEEG引导下RFTC是药物难治性局灶性癫痫安全且潜在的治疗选择。
  • RFTC后较长的无发作持续时间可能作为后续切除手术成功的预测指标。

研究设计与样本

  • 回顾性分析43例接受SEEG电极引导下RFTC的药物难治性局灶性癫痫患者,排除3例后对40例按手术方式和结局分组。
  • 24例(60%)接受二次切除手术,将延迟二次手术结局分为成功(Engel I/II)与失败(Engel III/IV),评估RFTC结局对后续手术结局的预测价值。

主要发现

  • 40例中20%仅经RFTC达到Engel I级,24例接受延迟二次切除手术。
  • 总体41.7%达到Engel I级,RFTC联合延迟手术成功率为66.7%。
  • 成功组无发作持续时间(平均4.9个月,SD=2.7)显著长于失败组(平均1.9个月,SD=1.1;P=0.007)。
  • 仅RFTC组和延迟手术成功组中术前存在病灶性发现的患者比例更高(p=0.01),并与更长的癫痫复发时间相关(p<0.05)。
  • 术后短暂并发症发生率为10%,均在一年内缓解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the safety and efficacy of stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation (RFTC) for drug-resistant focal epilepsy and investigate the relationship between post-RFTC remission duration and delayed excision surgery effectiveness. METHODS: We conducted a retrospective analysis of 43 patients with drug-resistant focal epilepsy who underwent RFTC via SEEG electrodes. After excluding three, the remaining 40 were classified into subgroups based on procedures and outcomes. Twenty-four patients (60%) underwent a secondary excision surgery. We determined the predictive value of RFTC outcome upon subsequent surgical outcome by categorizing the delayed secondary surgery outcome as success (Engel I/II) versus failure (Engel III/IV). Demographic information, epilepsy characteristics, and the duration of seizure freedom after RFTC were assessed. RESULTS: Among 40 patients, 20% achieved Engel class I with RFTC alone, while 24 underwent delayed secondary excision surgery. Overall, 41.7% attained Engel class I, with a 66.7% success rate combining RFTC with delayed surgery. Seizure freedom duration was significantly longer in the success group (mean 4.9 months, SD = 2.7) versus the failure group (mean 1.9 months, SD = 1.1; P = 0.007). A higher proportion of RFTC-only and delayed surgical success group patients had preoperative lesional findings (p = 0.01), correlating with a longer time to seizure recurrence (p < 0.05). Transient postoperative complications occurred in 10%, resolving within a year. CONCLUSION: This study demonstrates that SEEG-guided RFTC is a safe and potential treatment option for patients with drug-resistant focal epilepsy. A prolonged duration of seizure freedom following RFTC may serve as a predictive marker for the success of subsequent excision surgery.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Du C, Jin W, Wang L, et al. Stereoelectroencephalography-guided radiofrequency thermocoagulation of the epileptogenic zone: a potential treatment and prognostic indicator for subsequent excision surgery. Acta Neurochir (Wien). 2024. PMID: 38735896. doi:10.1007/s00701-024-06106-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。